Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Qualcomm and Arm tumble as the mobile-chip complex sinks on a broader market pullback, underscoring renewed risk-off ...
India restricts Telegram access ahead of the NEET-UG re-exam, hitting hundreds of millions of users and sending Gram ...
A recent insider sale of 5,595 Hilton Grand Vacations shares has investors asking what it means for the stock. This g...
When a sports contract becomes a financial puzzle, you learn what to watch for in any investment. This piece breaks d...
AngelList is terminating its Rail partnership with Ripple, ending crypto payments on the platform by July 31, 2026. T...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
Tesla trades around $370 as investors await Q2 2026 results, balancing a mature auto business with a growing software...
Air Lease stock posted a sharp 43% rally, yet a lease stock investor trims a sizable stake. This article breaks down ...
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
A famous actress names her favorite red carpet moment and a cringe-worthy style misstep. Learn how those fashion choi...